Recent News for OVID - Ovid Therapeutics Inc.

Date Title
Apr 18 Ovid Therapeutics to Present at the American Academy of Neurology 71st Annual Meeting
Apr 2 Sangamo Therapeutics and AVEO Pharmaceuticals among healthcare gainers; Advaxis and Evoke Pharma among losers
Apr 2 MNKD, TTM among premarket gainers
Mar 28 Ovid Therapeutics announces management changes
Mar 28 Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline
Mar 21 Ovid Therapeutics Announces Appointment of Pharmaceutical Veteran, Thomas Perone, as Senior Vice President, General Counsel and Corporate Secretary
Mar 7 Ovid Therapeutics reports Q4 results
Mar 7 Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 4 Ovid Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11
Feb 20 Why A Secondary Offering Is Often Negative For Stocks
Feb 20 Mid-Afternoon Market Update: Crude Oil Up 1.5%; Kandi Technologies Shares Spike Higher
Feb 20 54 Stocks Moving In Wednesday's Mid-Day Session
Feb 20 Mid-Day Market Update: LeMaitre Vascular Surges Following Strong Q4 Results; Sienna Biopharmaceuticals Shares Slide
Feb 20 Midday movers and shakers
Feb 20 LeMaitre Vascular leads healthcare gainers; CHF Solutions and Intercept Pharmaceuticals among losers
Feb 20 Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Feb 20 The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering
Feb 19 Ovid down 22% after hours on equity offering
Feb 19 Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
Feb 15 The Daily Biotech Pulse: Acorda Swings To Profit, Achaogen Offering, Bioblast Strikes Sanfilippo Syndrome Deal
Feb 7 Zynerba Stock Is Marijuana-Adjacent Play Worth a Look
Dec 28 The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO
Dec 25 How Much Of Ovid Therapeutics Inc. (NASDAQ:OVID) Do Insiders Own?
Dec 21 The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum

Back to the Main OVID Page...